ExodusPoint Capital Management’s Vigil Neuroscience VIGL Stock Holding History

ExodusPoint Capital Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-137,830	Closed	-$1.1M	–	2061
2025 Q2	$1.1M	Buy	+137,830	New	+$618K	0.01%	930

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

ExodusPoint Capital Management's VIGL Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 137,830 shares — an estimated $1.1M sold.

ExodusPoint Capital Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $1.1M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

ExodusPoint Capital Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 137,830 Vigil Neuroscience shares in Q3 2025, an estimated $1.1M.
ExodusPoint Capital Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
ExodusPoint Capital Management's Vigil Neuroscience position peaked at $1.1M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.